Home|Journals|Articles by Year|Audio Abstracts
 

Short Communication

J App Pharm Sci. 2021; 11(4): 153-158


Exploring the potentials of selected bioactive compounds isolated from Piper guineense Schumach. & Thonn. leaf toward identification of novel pfDHFR and pfDHODH inhibitors as antimalaria agents

Oluwafemi Adeleke Ojo.




Abstract
Cited by 5 Articles

Present antimalarial drugs have been related to several adverse side effects, including headache, depression, nausea, and itchy skin. Thus, exploring bioactive compounds from a natural origin, which possess drug-like properties with no side effects, is of great importance. This study was designed to assess the molecular relations obtainable between piperine, pipercide, and piperlongumine compounds isolated from Piper guineense Schumach. & Thonn. leaf and targeted receptor linked to malaria Plasmodium falciparum dihydrofolate reductase (pfDHFR) and Plasmodium falciparum dihydroorotate dehydrogenase (pfDHODH) for antimalarial properties. The result showed that piperine (−8.3 kcal/mol) from P. guineense binds to pfDHFR with high affinity and low free energy than the other compounds and standard ligand pyrimethamine (−7.8 kcal/mol). In contrast, pyrimethamine (−8.4 kcal/mol) and pipercide (−8.3 kcal/mol) show a better binding affinity to pfDHODH. Hence, the results provided insights into the development of better piperine and pipercide as a replacement to present antimalarial agents, with further analysis worth considering.

Key words: Piper guineense, molecular docking, pfDHFR, pfDHODH, rule of five, toxicity






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.